Novel immunologic therapies.
Although current allergen immunotherapy is an effective method of treating allergic inflammation, it is time consuming and carries the risk of anaphylaxis. Novel therapies for treating allergic inflammation are of two general types. In one senario, a key factor in the allergic cascade is blocked. The other possibility is to modify current immunotherapy administration.
Grammer
Leslie C
LC
Division of Allergy/Immunology, Department of Medicine, Northwestern University, Chicago, Illinois, USA.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003888:Desensitization, Immunologic / Q000379:methods; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy / Q000453:epidemiology; D007073:Immunoglobulin E / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy / Q000453:epidemiology; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D007073:Immunoglobulin E